Gabriel Maciel1, Cynthia S Crowson2, Eric L Matteson3, Divi Cornec4. 1. Division of Rheumatology, Mayo Clinic College of Medicine and Science, Rochester, MN; Hospital Maciel, Montevideo, Uruguay. 2. Division of Rheumatology, Mayo Clinic College of Medicine and Science, Rochester, MN; Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic College of Medicine and Science, Rochester, MN. 3. Division of Rheumatology, Mayo Clinic College of Medicine and Science, Rochester, MN; Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic College of Medicine and Science, Rochester, MN. Electronic address: matteson.eric@mayo.edu. 4. Division of Pulmonary and Critical Care Medicine, Mayo Clinic College of Medicine and Science, Rochester, MN; Rheumatology Department, Brest Teaching Hospital, Brest, France.
Abstract
OBJECTIVE: To estimate the incidence and mortality rates, and their evolution over time, of physician-diagnosed primary Sjögren syndrome (pSS) in residents of Olmsted County, Minnesota. PATIENTS AND METHODS: Medical records of patients with a diagnosis or suspicion of SS in Olmsted County from January 1, 2006, through December 31, 2015, were reviewed to identify incident cases of pSS (defined by physician diagnosis). These cases were combined with those from a 1976 through 2005 incident cohort (n=111) from the same population. Incidence rates were age and sex adjusted to the 2010 US white population. Survival rates were compared with the expected rates in the population of Minnesota. RESULTS: With 61 incident cases of pSS diagnosed in Olmsted County from 2006 through 2015, the total cohort included 172 patients with incident pSS from 1976 through 2015. Of the 172 patients, 151 (88%) were women and 161 (94%) were white, with a mean ± SD age at diagnosis of 58.3±16.7 years. The average age- and sex-adjusted annual incidence for 2006 through 2015 was 5.9 per 100,000 population (95% CI, 4.4-7.4 per 100,000 population), and the overall incidence for the entire period was 5.8 per 100,000 (95% CI, 4.9-6.6 per 100,000). The incidence increased with calendar time over the 40-year period (P=.005). There was no difference in mortality in the pSS cohort compared with expected (standardized mortality ratio, 1.15; 95% CI, 0.86-1.50). CONCLUSION: The average annual incidence of pSS in this population-based cohort was 5.8 per 100,000, with a progressive increase over the 40 years of the study. Overall survival of patients with pSS was not different from that of the general population.
OBJECTIVE: To estimate the incidence and mortality rates, and their evolution over time, of physician-diagnosed primary Sjögren syndrome (pSS) in residents of Olmsted County, Minnesota. PATIENTS AND METHODS: Medical records of patients with a diagnosis or suspicion of SS in Olmsted County from January 1, 2006, through December 31, 2015, were reviewed to identify incident cases of pSS (defined by physician diagnosis). These cases were combined with those from a 1976 through 2005 incident cohort (n=111) from the same population. Incidence rates were age and sex adjusted to the 2010 US white population. Survival rates were compared with the expected rates in the population of Minnesota. RESULTS: With 61 incident cases of pSS diagnosed in Olmsted County from 2006 through 2015, the total cohort included 172 patients with incident pSS from 1976 through 2015. Of the 172 patients, 151 (88%) were women and 161 (94%) were white, with a mean ± SD age at diagnosis of 58.3±16.7 years. The average age- and sex-adjusted annual incidence for 2006 through 2015 was 5.9 per 100,000 population (95% CI, 4.4-7.4 per 100,000 population), and the overall incidence for the entire period was 5.8 per 100,000 (95% CI, 4.9-6.6 per 100,000). The incidence increased with calendar time over the 40-year period (P=.005). There was no difference in mortality in the pSS cohort compared with expected (standardized mortality ratio, 1.15; 95% CI, 0.86-1.50). CONCLUSION: The average annual incidence of pSS in this population-based cohort was 5.8 per 100,000, with a progressive increase over the 40 years of the study. Overall survival of patients with pSS was not different from that of the general population.
Authors: Steven E Carsons; Frederick B Vivino; Ann Parke; Nancy Carteron; Vidya Sankar; Richard Brasington; Michael T Brennan; William Ehlers; Robert Fox; Hal Scofield; Katherine M Hammitt; Julius Birnbaum; Stuart Kassan; Steven Mandel Journal: Arthritis Care Res (Hoboken) Date: 2017-03-03 Impact factor: 4.794
Authors: Divi Cornec; Valérie Devauchelle-Pensec; Xavier Mariette; Sandrine Jousse-Joulin; Jean-Marie Berthelot; Aleth Perdriger; Xavier Puéchal; Véronique Le Guern; Jean Sibilia; Jacques-Eric Gottenberg; Laurent Chiche; Eric Hachulla; Pierre Yves Hatron; Vincent Goeb; Gilles Hayem; Jacques Morel; Charles Zarnitsky; Jean Jacques Dubost; Philippe Saliou; Jacques Olivier Pers; Raphaèle Seror; Alain Saraux Journal: Arthritis Care Res (Hoboken) Date: 2017-04 Impact factor: 4.794
Authors: Jennifer L St Sauver; Brandon R Grossardt; Barbara P Yawn; L Joseph Melton; Walter A Rocca Journal: Am J Epidemiol Date: 2011-03-23 Impact factor: 4.897
Authors: Anna P Risselada; Aike A Kruize; Roel Goldschmeding; Floris P J G Lafeber; Johannes W J Bijlsma; Joel A G van Roon Journal: Ann Rheum Dis Date: 2014-02-13 Impact factor: 19.103
Authors: Barbara M Segal; Brian Pogatchnik; Lisa Henn; Kyle Rudser; Kathy Moser Sivils Journal: Arthritis Care Res (Hoboken) Date: 2013-08 Impact factor: 4.794
Authors: Astrid Rasmussen; Lida Radfar; David Lewis; Kiely Grundahl; Donald U Stone; C Erick Kaufman; Nelson L Rhodus; Barbara Segal; Daniel J Wallace; Michael H Weisman; Swamy Venuturupalli; Biji T Kurien; Christopher J Lessard; Kathy L Sivils; R Hal Scofield Journal: Rheumatology (Oxford) Date: 2016-03-21 Impact factor: 7.580
Authors: Luisa Servioli; Gabriel Maciel; Carlotta Nannini; Cynthia S Crowson; Eric L Matteson; Divi Cornec; Alvise Berti Journal: J Rheumatol Date: 2019-01-15 Impact factor: 4.666
Authors: Peter M Izmirly; Jill P Buyon; Isabella Wan; H Michael Belmont; Sara Sahl; Jane E Salmon; Anca Askanase; Joan M Bathon; Laura Geraldino-Pardilla; Yousaf Ali; Ellen M Ginzler; Chaim Putterman; Caroline Gordon; Charles G Helmick; Hilary Parton Journal: Arthritis Care Res (Hoboken) Date: 2019-05-23 Impact factor: 4.794
Authors: Gabriel Maciel; Luisa Servioli; Carlotta Nannini; Alvise Berti; Cynthia S Crowson; Sara J Achenbach; Eric L Matteson; Divi Cornec Journal: RMD Open Date: 2018-02-28